EUVIMEDUpptäck EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19

Cameron D Owens iD, Camila Bonin Pinto, Sam Detwiler, Lauren Olay, Ana Clara da C Pinaffi-Langley, Peter Mukli, Anna Peterfi, Zsofia Szarvas, Judith A James, Veronica Galvan, Stefano Tarantini, Anna Csiszar and 4 more

Brain Communications · 2024-03-01 · 6 (2)

DOI: 10.1093/braincomms/fcae080 ↗

At a glance

Übersichtsarbeit in Brain Communications, published online on 2024-03-07. Written by Cameron D Owens and 15 co-authors. Institution: Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA. Cited 36 times so far (Crossref); 311 references. The full text is freely available (open access, CC BY 4.0). Funded by: CSRD VA, BLRD VA, NIA NIH HHS.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Components that comprise our brain parenchymal and cerebrovascular structures provide a homeostatic environment for proper neuronal function to ensure normal cognition. Cerebral insults (e.g. ischaemia, microbleeds and infection) alter cellular structures and physiologic processes within the neurovascular unit and contribute to cognitive dysfunction. COVID-19 has posed significant complications during acute and convalescent stages in multiple organ systems, including the brain. Cognitive impairment is a prevalent complication in COVID-19 patients, irrespective of severity of acute SARS-CoV-2 infection. Moreover, overwhelming evidence from in vitro, preclinical and clinical studies has reported SARS-CoV-2-induced pathologies in components of the neurovascular unit that are associated with cognitive impairment. Neurovascular unit disruption alters the neurovascular coupling response, a critical mechanism that regulates cerebromicrovascular blood flow to meet the energetic demands of locally active neurons. Normal cognitive processing is achieved through the neurovascular coupling response and involves the coordinated action of brain parenchymal cells (i.e. neurons and glia) and cerebrovascular cell types (i.e. endothelia, smooth muscle cells and pericytes). However, current work on COVID-19-induced cognitive impairment has yet to investigate disruption of neurovascular coupling as a causal factor. Hence, in this review, we aim to describe SARS-CoV-2's effects on the neurovascular unit and how they can impact neurovascular coupling and contribute to cognitive decline in acute and convalescent stages of the disease. Additionally, we explore potential therapeutic interventions to mitigate COVID-19-induced cognitive impairment. Given the great impact of cognitive impairment associated with COVID-19 on both individuals and public health, the necessity for a coordinated effort from fundamental scientific research to clinical application becomes imperative. This integrated endeavour is crucial for mitigating the cognitive deficits induced by COVID-19 and its subsequent burden in this especially vulnerable population.

Subjects

Author keywords

SARS-CoV-2cognitive impairmentendotheliumneurovascular uncouplingoxidative stress

Authors and institutions

  • Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
  • Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health, Translational Medicine and Physiology, Semmelweis University, Budapest, 1089, Hungary.
  • Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
  • Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

ORCID profiles: Cameron D Owens, Andriy Yabluchanskiy

Funding

  • CSRD VA
  • BLRD VA
  • NIA NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • National Institute on Aging
  • American Heart Association

Cite

APA

Owens, C. D., Bonin Pinto, C., Detwiler, S., Olay, L., Pinaffi-Langley, A. C. D. C., Mukli, P., Peterfi, A., Szarvas, Z., James, J. A., Galvan, V., Tarantini, S., Csiszar, A., Ungvari, Z., Kirkpatrick, A. C., Prodan, C. I., & Yabluchanskiy, A. (2024). Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19. Brain Communications, 6(2). https://doi.org/10.1093/braincomms/fcae080

Vancouver

Owens CD, Bonin Pinto C, Detwiler S, Olay L, Pinaffi-Langley ACDC, Mukli P, et al. Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19. Brain Communications. 2024;6(2). doi:10.1093/braincomms/fcae080

BibTeX
@article{Owens2024,
  author = {Owens, Cameron D and Bonin Pinto, Camila and Detwiler, Sam and Olay, Lauren and Pinaffi-Langley, Ana Clara da C and Mukli, Peter and Peterfi, Anna and Szarvas, Zsofia and James, Judith A and Galvan, Veronica and Tarantini, Stefano and Csiszar, Anna and Ungvari, Zoltan and Kirkpatrick, Angelia C and Prodan, Calin I and Yabluchanskiy, Andriy},
  title = {Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19},
  journal = {Brain Communications},
  year = {2024},
  volume = {6},
  number = {2},
  doi = {10.1093/braincomms/fcae080}
}
Start for free →